Epidemiological characteristics of leprosy from 2000 to 2019 in a state with low endemicity in southern Brazil
Anais Brasileiros de Dermatologia · 2023-09 · 98 (5) · 602-610
DOI: 10.1016/j.abd.2022.08.009 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Anais Brasileiros de Dermatologia, 2023-09. Verfasst von Paulo Cezar de Moraes und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Sanitary Dermatology, Sanitary Dermatology Outpatient Clinic, State Health Secretariat of Rio Grande do Sul, Porto Alegre, RS, Brazil; …. Hauptthemen laut MEDLINE: Leprosy, Persons with Disabilities. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Leprosy is an infectious and contagious disease caused by Mycobacterium leprae and is mainly characterized by lesions in the skin and peripheral nerves. In Brazil, it is a public health problem due to its high endemicity. However, the state of Rio Grande do Sul presents low endemicity of this disease.
Objective
To characterize the epidemiological profile of leprosy in the state of Rio Grande do Sul from 2000 to 2019.
Methods
This was a retrospective observational study. Epidemiological data were collected from the Notifiable Diseases Information System (SINAN, Sistema de Informação de Agravos de Notificação).
Results
Among the 497 municipalities in the state, 357 (71.8%) registered cases of leprosy in the assessed period, with an average of 212 (81.5%) new cases per year. The average detection rate was 1.61 new cases per 100,000 inhabitants. The male sex was predominant (51.9%) and the mean age was 50.4 years. Regarding the epidemiological clinical profile; 79.0% of the patients were multibacillary; 37.5% presented the borderline clinical form; 16% had grade 2 physical disability at diagnosis and bacilloscopy was positive in 35.4% of cases. As for treatment, 73.8% of the cases were treated with the standard multibacillary therapeutic regimen. Study limitations There were missing/inconsistent data in the database available.
Conclusions
The findings observed in this study indicate that the state presents a low endemicity profile of the disease and these results can support adequate health policies relevant to the reality of Rio Grande do Sul, inserted in a national scenario of highly endemic leprosy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Sanitary Dermatology, Sanitary Dermatology Outpatient Clinic, State Health Secretariat of Rio Grande do Sul, Porto Alegre, RS, Brazil; Postgraduation Program in Medicine ‒ Medical Sciences, Universidade Fe…
- Department of Sanitary Dermatology, Sanitary Dermatology Outpatient Clinic, State Health Secretariat of Rio Grande do Sul, Porto Alegre, RS, Brazil.
- Department of Microbiology, Immunology and Parasitology, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil; Postgraduation Program in Medicine ‒ Medical Sciences, Universidade Federal do Rio Grande do…
Zitieren
APA
Moraes, P. C., Eidt, L. M., Koehler, A., Ransan, L. G., & Scrofeneker, M. L. (2023). Epidemiological characteristics of leprosy from 2000 to 2019 in a state with low endemicity in southern Brazil. Anais Brasileiros de Dermatologia, 98(5), 602-610. https://doi.org/10.1016/j.abd.2022.08.009
Vancouver
Moraes PC, Eidt LM, Koehler A, Ransan LG, Scrofeneker ML. Epidemiological characteristics of leprosy from 2000 to 2019 in a state with low endemicity in southern Brazil. Anais Brasileiros de Dermatologia. 2023;98(5):602-610. doi:10.1016/j.abd.2022.08.009
BibTeX
@article{Moraes2023,
author = {Moraes, Paulo Cezar de and Eidt, Letícia Maria and Koehler, Alessandra and Ransan, Leonardo Girardi and Scrofeneker, Maria Lúcia},
title = {Epidemiological characteristics of leprosy from 2000 to 2019 in a state with low endemicity in southern Brazil},
journal = {Anais Brasileiros de Dermatologia},
year = {2023},
volume = {98},
number = {5},
pages = {602--610},
doi = {10.1016/j.abd.2022.08.009}
}
EUVIMED